NKTR 171

Drug Profile

NKTR 171

Alternative Names: NKTR-171

Latest Information Update: 03 Nov 2015

Price : $50

At a glance

  • Originator Nektar Therapeutics
  • Class Analgesics; Drug conjugates; Tricyclic antidepressants
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Neuropathic pain

Most Recent Events

  • 01 Jan 2014 Phase-I clinical trials in Neuropathic pain (in volunteers) in USA (PO)
  • 15 Oct 2012 Pharmacodynamics data from a preclinical trial in Neuropathic pain presented at the 42nd Annual Meeting SfN - Neuroscience 2012 (SfN-2012) ,
  • 04 Apr 2012 Preclinical trials in Neuropathic pain in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top